Saskia Sperber
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Metabolomics and Mass Spectrometry Studies 12
- Gut microbiota and health 8
-
- Pharmacogenetics and Drug Metabolism 6
- Ginger and Zingiberaceae research 2
- Co-authors
- Hennicke Kamp (17 shared papers)Tilmann Walk (12 shared papers)Bennard van Ravenzwaay (17 shared papers)Michael Spitzer (3 shared papers)Volker Strauss (5 shared papers)Michael Herold (4 shared papers)W. Mellert (3 shared papers)Xiaoqi Jiang (3 shared papers)
- Journals
- Toxicology Letters (7 papers)Regulatory Toxicology and Pharmacology (2 papers)Archives of Toxicology (2 papers)Toxicology and Applied Pharmacology (2 papers)Engineering in Life Sciences (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Saskia Sperber
24 papers receiving 399 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 52
- Chemical Health and Safety 4
- Health, Toxicology and Mutagenesis 63
- Biological Psychiatry 10
- Small Animals 27
Countries citing papers authored by Saskia Sperber
This map shows the geographic impact of Saskia Sperber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia Sperber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia Sperber more than expected).
Fields of papers citing papers by Saskia Sperber
This network shows the impact of papers produced by Saskia Sperber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia Sperber. The network helps show where Saskia Sperber may publish in the future.
Co-authors
The 25 scholars most cited alongside Saskia Sperber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 124 | |
| 2 | 2018 | 46 | |
| 3 | 2016 | 42 | |
| 4 | 2019 | 29 | |
| 5 | 2018 | 29 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2018 | 13 | |
| 11 | Atrial natriuretic peptide in gentamicin-induced acute renal failure. | 1988 | 11 |
| 12 | 2018 | 9 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2015 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2017 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2018 | 2 |
About Saskia Sperber
Saskia Sperber is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Biomedical Engineering and Infectious Diseases, having authored 24 papers that have together received 405 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (12 papers), Gut microbiota and health (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Computational Drug Discovery Methods (4 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Ginger and Zingiberaceae research (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Pharmacology (52 citations), Chemical Health and Safety (4 citations), Health, Toxicology and Mutagenesis (63 citations), Biological Psychiatry (10 citations) and Small Animals (27 citations). Saskia Sperber has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Hennicke Kamp, Tilmann Walk, Bennard van Ravenzwaay, Michael Spitzer, Volker Strauss, Michael Herold, W. Mellert, Xiaoqi Jiang, Alexander Strigun and Thomas Härtung. Their work appears in journals such as Toxicology Letters, Regulatory Toxicology and Pharmacology, Archives of Toxicology, Toxicology and Applied Pharmacology and Engineering in Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.